{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:20:38Z","timestamp":1791037238853,"version":"4.1.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T00:00:00Z","timestamp":1298419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017287","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T01:21:01Z","timestamp":1298510461000},"page":"e17287","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":98,"title":["Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome"],"prefix":"10.1371","volume":"6","author":[{"given":"Steven E.","family":"Schutzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena A.","family":"Schepmoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese R.","family":"Clauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua N.","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart K.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia K.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Natelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,2,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.","volume":"121","author":"K Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CDLI.12.1.52-55.2005","article-title":"Spinal fluid abnormalities in patients with chronic fatigue syndrome.","volume":"12","author":"BH Natelson","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2008-1041176","article-title":"Neurologic Lyme disease.","volume":"12","author":"PK Coyle","year":"1992","journal-title":"Semin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.35.1.47","article-title":"The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.","volume":"35","author":"AR Pachner","year":"1985","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/314860","article-title":"Successful treatment of Lyme encephalopathy with intravenous ceftriaxone.","volume":"180","author":"EL Logigian","year":"1999","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease.","volume":"323","author":"EL Logigian","year":"1990","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archneur.1997.00550230045015","article-title":"Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences.","volume":"54","author":"EA Gaudino","year":"1997","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/457155a","article-title":"Immunology: Barrier to electrical storms.","volume":"457","author":"RM Ransohoff","year":"2009","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nmeth.f.255","article-title":"A stress test for mass spectrometry-based proteomics.","volume":"6","author":"R Aebersold","year":"2009","journal-title":"Nat Methods"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e10980","DOI":"10.1371\/journal.pone.0010980","article-title":"Establishing the proteome of normal human cerebrospinal fluid.","volume":"5","author":"SE Schutzer","year":"2010","journal-title":"PLoS ONE"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nbt.1546","article-title":"Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.","volume":"27","author":"TA Addona","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cbpa.2009.08.016","article-title":"Directed mass spectrometry: towards hypothesis-driven proteomics.","volume":"13","author":"A Schmidt","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/pr1008515","article-title":"On the development of plasma protein biomarkers.","volume":"10","author":"S Surinova","year":"2011","journal-title":"J Proteome Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.53.6.1340","article-title":"Absence of Borrelia burgdorferi-specific immune complexes in chronic fatigue syndrome.","volume":"53","author":"SE Schutzer","year":"1999","journal-title":"Neurology"},{"key":"ref15","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.","volume":"43","author":"GP Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.","volume":"70","author":"BA Fallon","year":"2008","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1074\/mcp.T600039-MCP200","article-title":"Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.","volume":"5","author":"T Liu","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W","article-title":"An accurate mass tag strategy for quantitative and high-throughput proteome measurements.","volume":"2","author":"RD Smith","year":"2002","journal-title":"Proteomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1074\/mcp.M600068-MCP200","article-title":"High dynamic range characterization of the trauma patient plasma proteome.","volume":"5","author":"T Liu","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/bioinformatics\/btn063","article-title":"DeconMSn: a software tool for accurate parent ion monoisotopic mass determination for tandem mass spectra.","volume":"24","author":"AM Mayampurath","year":"2008","journal-title":"Bioinformatics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nmeth1019","article-title":"Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.","volume":"4","author":"JE Elias","year":"2007","journal-title":"Nat Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/pr025556v","article-title":"Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC\/LC-MS\/MS) for large-scale protein analysis: the yeast proteome.","volume":"2","author":"J Peng","year":"2003","journal-title":"J Proteome Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/pr0498638","article-title":"Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome.","volume":"4","author":"WJ Qian","year":"2005","journal-title":"J Proteome Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/bioinformatics\/btm281","article-title":"VIPER: an advanced software package to support high-throughput LC-MS peptide identification.","volume":"23","author":"ME Monroe","year":"2007","journal-title":"Bioinformatics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mas.20071","article-title":"Advances in proteomics data analysis and display using an accurate mass and time tag approach.","volume":"25","author":"JS Zimmer","year":"2006","journal-title":"Mass Spectrom Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1101\/gr.5799207","article-title":"Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry.","volume":"17","author":"VA Petyuk","year":"2007","journal-title":"Genome Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry.","volume":"75","author":"AI Nesvizhskii","year":"2003","journal-title":"Anal Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/bioinformatics\/btn217","article-title":"DAnTE: a statistical tool for quantitative analysis of -omics data.","volume":"24","author":"AD Polpitiya","year":"2008","journal-title":"Bioinformatics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1073\/pnas.2232515100","article-title":"Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson&apos;s disease.","volume":"100","author":"PD Smith","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/371423a0","article-title":"A brain-specific activator of cyclin-dependent kinase 5.","volume":"371","author":"J Lew","year":"1994","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nbt.1661","article-title":"Options and considerations when selecting a quantitative proteomics strategy.","volume":"28","author":"B Domon","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nbt0710-665","article-title":"Proteomics retrenches.","volume":"28","author":"P Mitchell","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/pr800538n","article-title":"Mass spectrometry based targeted protein quantification: methods and applications.","volume":"8","author":"S Pan","year":"2009","journal-title":"J Proteome Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1235","article-title":"Protein biomarker discovery and validation: the long and uncertain path to clinical utility.","volume":"24","author":"N Rifai","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molonc.2008.12.001","article-title":"Targeted proteomic strategy for clinical biomarker discovery.","volume":"3","author":"R Schiess","year":"2009","journal-title":"Mol Oncol"},{"key":"ref37","article-title":"Enhanced sensitivity for selected reaction monitoring-mass spectrometry-based targeted proteomics using a dual-stage electrodynamic ion funnel interface.","author":"M Hossain","year":"2010"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1128\/AEM.00966-08","article-title":"Criteria for validation of methods in microbial forensics.","volume":"74","author":"B Budowle","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"46ps42","DOI":"10.1126\/scitranslmed.3001249","article-title":"Recommendations for biomarker identification and qualification in clinical proteomics.","volume":"2","author":"H Mischak","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8cm7","DOI":"10.1126\/scitranslmed.3000372","article-title":"Use of forensic methods under exigent circumstances without full validation.","volume":"1","author":"SE Schutzer","year":"2009","journal-title":"Sci Transl Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T21:34:43Z","timestamp":1592343283000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017287"}},"subtitle":[],"editor":[{"given":"Howard","family":"Gendelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,23]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017287","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,23]]}}}